Form 4 for ENTA ENANTA PHARMACEUTICALS INC
Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-01 · accession 0001062993-21-012213 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-03 | 2021-12-01 | ENTA | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $86.35 | -13.5K | 32.9K | -29% | -$1.17M |
| DM | 2021-12-03 | 2021-12-01 | ENTA | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $45.25 | +13.5K | 41.7K | +48% | +$611.9K |
| D | 2021-12-03 | 2021-12-01 | ENTA | Adda Nathalie | SVP, Chief Medical Off | F - Tax | $87.68 | -842 | 32.9K | -2% | -$73.8K |
| DM | 2021-12-03 | 2021-12-01 | ENTA | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $0.00 | -13.5K | 46.0K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-01 | S | D | 1,500 | $87.60 | 34,902 | D | — | — | (F6) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $87.23 to $87.92, inclusive. |
| 2 | Common | Common Stock | 2021-12-01 | M | A | 4,773 | $48.52 | 46,425 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-01 | S | D | 1,587 | $84.81 | 44,838 | D | — | — | (F3) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.43 to $84.98, inclusive. |
| 4 | Common | Common Stock | 2021-12-01 | S | D | 5,736 | $85.49 | 39,102 | D | — | — | (F4) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $85.04 to $85.98, inclusive. |
| 5 | Common | Common Stock | 2021-12-01 | S | D | 2,700 | $86.45 | 36,402 | D | — | — | (F5) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $86.03 to $86.91, inclusive. |
| 6 | Common | Common Stock | 2021-12-01 | M | A | 8,750 | $43.46 | 41,652 | D | — | — | |
| 7 | Common | Common Stock | 2021-12-01 | S | D | 900 | $88.31 | 34,002 | D | — | — | (F7) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $88.01 to $88.90, inclusive. |
| 8 | Common | Common Stock | 2021-12-01 | S | D | 899 | $89.33 | 33,103 | D | — | — | (F8) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $89.02 to $89.88, inclusive. |
| 9 | Common | Common Stock | 2021-12-01 | S | D | 201 | $90.17 | 32,902 | D | — | — | (F9) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.25, inclusive. |
| 10 | Common | Common Stock | 2021-12-01 | F | D | 842 | $87.68 | 32,902 | D | — | — | (F1) Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 20, 2020. |
| 11 | Derivative | Stock Option (Right to Buy) | 2021-12-01 | M | D | 4,773 | $0.00 | 9,180 | D | $48.52 · — to 2027-11-17 | 4,773 Common Stock | (F10) 100% of the shares subject to the option are fully vested and exercisable. |
| 12 | Derivative | Stock Option (Right to Buy) | 2021-12-01 | M | D | 8,750 | $0.00 | 46,020 | D | $43.46 · — to 2025-06-29 | 8,750 Common Stock | (F10) 100% of the shares subject to the option are fully vested and exercisable. |